lixisenatide vs semaglutide Oral GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies Designing GLP-1 delivery: structural perspectives

Recent research has identified additional mechanisms of action, including pleiotropic effects such as suppressing cancer growth and attenuating cell oxidative stress and inflammation

Semaglutide is a revolutionary FDA-approved weight loss injection that helps regulate appetite, control cravings, and promote sustainable weight loss

Trial averages do not determine the best treatment for every individual

It is also often associated with obesity and can lead to symptoms caused by high levels of male hormones (androgens)

Editorial: aging and male hypogonadism

We selected multiple molecular phenotypes here since the association across multiple independent datasets can strengthen the robustness of the findings